The substituted benzothiazole derivatives have antitumor 1 , melting point apparatus and are uncorrected; UV spectra vasodilator 2 , antitubercular 3 , antifungal 4 , CNS 5 activities. The were recorded on UV-1601 2-(4-aminophenyl) benzothiazoles are a novel class of potent spectrophotometer (Shimadzu). IR spectra were recorded and selective antitumor agents and display a characteristic in KBr disc on a FTIR 8300, KBr Press (Shimadzu) profile of cytotoxicity response across the cell lines; sensitive spectrometer at MCOPS, Manipal. . Since they display potent and selective antitumor physical data of the derivatives are listed in Table 1 . The activity against interalia breast, ovarian, colon and renal cell scheme of synthesis is given in Schemes 1, 2 and 3. lines, we thought it worthwhile to check for their antitumor activity against human cervical cancer cell lines. A compound 2-(2-chloro-4-fluorophenyl)-benzothiazole (SBCF): NCB [2-(3-bromo-4-aminophenyl) benzothiazole showed Equimolar quantities of o-aminothiophenol (0.04 mol) and substantial in-vitro activity against breast cancer cell lines 2-chloro-4-fluorobenzoic acid were added to 15 g of MCF-7 (ER   +   ) 6 NCB, 2-arylsubstituted benzothiazoles and polyphosphoric acid and refluxed for 4 h at 220°. The their carbothioates with various substituents on the phenyl reaction mixture was cooled and poured in ice cold 10% ring were therefore synthesized. Comparison of antitumor sodium carbonate solution. The precipitate was filtered activities of the synthesized compounds against human and recrystallized from methanol. IR (KBr) cm -1 : 3050.0 PC, UV/Vis cervical cancer cell lines was performed by in vitro cytotoxicity study on Ehrlich Ascitic Carcinoma (Tryphan blue exclusion assay) and MTT cell proliferation assay according to the protocol of ATCC (American Type Cell Culture collection) using human cervical cancer cell lines (SiHa). In vivo cytotoxicity study on Ehrlich Ascitic Carcinoma induced Swiss albino mice was also performed.
MATERIALS AND METHODS
Melting points were determined on a Toshniwal Scientific phenyl] benzothiazole (0.04 mol) was dissolved in 50 ml of dichloromethane and bromine in 10 ml of dichloromethane was added to it. The reaction mixture was vigorously stirred for 2 min at -5°. Then 400 ml of cold water was added to it and stirred for 1 h the organic layer was shaken with sodium thiosulfate solution, washed 
1,3-benzothiazol-2-yl-4-aminobenzene carbothiaote (SBSNH):
A quantity equivalent to 0.01 mol of 4-aminobenzoic acid and 0.04 mol of thionyl chloride were magnetically stirred and refluxed at 70° for 1 h. The excess of thionyl chloride was removed from the reaction mixture by distilling with benzene to get the acid chloride. 0.01 mol of the acid chloride and 0.01 mol of 2-mercaptobenzothiazole were dissolved in 25 ml pyridine and heated on water-bath for 15 min. The reaction mixture was cooled and poured in ice-cold water to get the precipitate that was later recrystallized from methanol. IR (KBr) cm 
In vitro cytotoxicity of compounds on EAC (Ehrlich Ascitic Carcinoma):
All the synthesized compounds were screened for antitumor activity 7 by tryphan blue exclusion method. The compounds were dissolved in DMSO to obtain the 
1,3-benzothiazol-2-yl-4-nitrobenzene carbothiaote (SBSNO):
A quantity equivalent to 0.01 mol of 4-nitrobenzoic acid and 0.04 mol of thionyl chloride were magnetically stirred and refluxed at 70 0 for 1 h. The excess of thionyl chloride was removed from the reaction mixture by distilling with benzene to get the acid chloride. The acid chloride (0.01 mol) and 0.01 mol of 2 mercaptobenzothiazole were dissolved in 25 ml pyridine and heated on water-bath for 15 min. The reaction mixture was cooled and poured in ice-cold water to get were dissolved in 25 ml of pyridine and refluxed for 4 h, cooled and poured in cold water. The mixture was filtered after 1 h and the precipitate recrystallized from methanol to concentration of 1000 µg/ml. An aliquot (500 µl) of the EAC cell suspension in phosphate buffer saline (1×10 -6 cells per ml) was taken and 50 µl of the solution of the compounds was added to it. It was incubated at 37° for 4 h in 5% CO 2 atmosphere. Then 25 µl of tryphan blue solution was added to it. The dead (blue coloured) and live (no colour) cells were counted in haemocytometer. The results are expressed as % cell death (Table 2) .
In vitro cytotoxicity studies on human cervical cell lines:
In vitro cytotoxicity studies were carried out on human cervical cell lines (SiHa). Cell suspension (100 µl×10 -6 cells per ml) was transferred to each well of a 96 well flat The tumor response was assessed on the basis of mean SBSNO 44 survival time (MST) and % increase in life span (%ILS).
SBSNH 90
%ILS={MST(treated)-MST(control)}×100/MST(control). As bottom micro plate. It was incubated at 37° for 24 h in 5%
per the literature survey if the %ILS is more than 125% then the drug is considered to be an effective antitumor CO 2 . Then 10 µl of concentration of drug at different agent. For statistical analysis one way ANOVA with post concentrations were added and incubated for 44 h. MTT hoc Scheffe's test was applied to all the parameters. solution (20 µl) was added to each well and incubated for (Table 4 ) 4 h. Purple color was developed after incubation. Isopropyl alcohol: HCl (4 N) (1:100) mixture (100 µl) was
RESULTS AND DISCUSSION
added to each well. The absorbances were noted at 570 nm and at 630 nm and compared with control. The Screening for antitumor activity included measurement of results are expressed as % cell death at different conc.
% cell death of EAC by tryphan blue exclusion assay. viz. 1000, 500, 250, 100 µg/ml (Table 3) The compounds SBCF, SBNCB, SBSNH were found to be significantly cytotoxic compared to the other Acute toxicity studies:
derivatives. So, these were selected for in vivo screening The compounds were weighed and formulated into a of antitumor activity using Swiss mice. Cisplatin was the
. m e d k n o w . c o m
) .
suspension using 2% acacia. The solvent used was standard drug for comparison and it was found that double distilled water. The required dose of the drugs SBNCB, SBCF, SBSNH had significantly increased the was given daily for 9 d intraperitonially. The LD 50 for all %ILS i.e., ILS>125%. The difference in the mean the compounds was found out.
between cisplatin, SBCF, SBNCB, SBSNH groups and control groups was found to be significant (p> 0.05). At In vivo studies on EAC induced Swiss Albino 1000 µg/ml, only SBNCB showed good activity on cell mice:
growth inhibition of cervical cancer cell lines. SBSNH The ascitic fluid from ascitic tumor bearing mice (donor) and SBCF showed moderate cytotoxicity whereas others showed poor activity. At 500 µg/ml, the activity of all the showed cytotoxicity.
% Cell death at different conc.
1000 µ µ µ µ µg/ml 500 µ µ µ µ µg/ml 250 µ µ µ µ µg/ml 100 µ µ µ µ µg/ml 
155.76
One way ANOVA by using SPSS 9.0 computer package.
a -values in mean±SEM, p< 0.05 survey 1 . SBNCB, SBSNH, SBCF showed higher cytotoxicity than NCB.
The cytotoxicity of the compound containing N(CH 2 CH 2 Cl) 2 at para position is more than the compounds having -NH 2 at para position on the phenyl ring attached to the benzothiazole. Replacing chlorine in SBCF by -N(CH 2 CH 2 Cl) 2 reduced the activity in in vitro assay on EAC cells to one half the original activity. Compounds with -NH 2 at meta position on the phenyl ring decrease the cytotoxicity. Compounds with more than one halogen exhibited better cytotoxicity. Meta substituted derivatives were less cytotoxic. Nitro-substituted derivatives were the least cytotoxic of the compounds synthesized. www.ijpsonline.com
